Angiogene Pharmaceuticals Ltd.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Angiogene Pharmaceuticals Ltd..The latest application filed is for "method and composition for alleviating tumor symptoms".
- Angiogene Pharmaceuticals Ltd. - Watington, OX CA GB
- Angiogene Pharmaceuticals Ltd. - Oxfordshire GB
- ANGIOGENE, PHARMACEUTICALS LIMITED - Oxfordshire GB
- ANGIOGENE PHARMACEUTICALS LIMITED - The Magdalen Centre, The Oxford Science Park, Oxfordshire GB
- Angiogene Pharmaceuticals Ltd. -
- Angiogene Pharmaceuticals Ltd. - Watlington GB
- Angiogene Pharmaceuticals Limited - Oxford GB
| Patent | Date |
|---|---|
| Method and Composition for Alleviating Tumor Symptoms App 20150141349 - Davis; Peter David ; et al. | 2015-05-21 |
| Benzimidazole vascular damaging agents Grant 7,875,727 - Davis January 25, 2 | 2011-01-25 |
| Bioreductively-Activated Prodrugs App 20080145372 - Davis; Peter David ; et al. | 2008-06-19 |
| Substituted stilbene compounds with vascular damaging activity Grant 7,265,136 - Davis September 4, 2 | 2007-09-04 |
| Bioreductively-activated prodrugs App 20070099871 - Davis; Peter David ; et al. | 2007-05-03 |
| Benzimidazole vascular damaging agents App 20060264492 - Davis; Peter David | 2006-11-23 |
| Colchinol derivatives as vascular damaging agents Grant 7,135,502 - Davis , et al. November 14, 2 | 2006-11-14 |
| Compositions with vascular damaging activity Grant 7,105,501 - Davis September 12, 2 | 2006-09-12 |
| Combinations for the treatment of diseases involving angiogenesis App 20060198846 - Davis; Peter David | 2006-09-07 |
| Combinations for the treatment of diseases involving angiogenesis Grant 7,087,627 - Davis August 8, 2 | 2006-08-08 |
| Benzimidazole vascular damaging agents Grant 7,081,469 - Davis July 25, 2 | 2006-07-25 |
| Colchinol derivatives as vascular damaging agents App 20060128633 - Davis; Peter D. ; et al. | 2006-06-15 |
| Colchinol derivatives as angiogenesis inhibitors Grant 6,846,925 - Arnould January 25, 2 | 2005-01-25 |
| Colchinol derivatives as angiogenesis inhibitors App 20040142909 - Arnould, Jean Claude | 2004-07-22 |
| Colchinol derivatives as angiogenesis inhibitors Grant 6,720,323 - Arnould April 13, 2 | 2004-04-13 |
| Benzimidazole vascular damaging agents Grant 6,645,950 - Davis November 11, 2 | 2003-11-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 